TB: Clinical Trials

5 trials for TB, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 active not recruiting, 1 recruiting, 1 withdrawn. 5 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable5Completed 2, Active not recruiting 1, Recruiting 1, Withdrawn 1

Follow TB: new trials by email Literature Review of TB trials Research Report on TB

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Parent Study Name: Pulmonary Rehabilitation to Reduce Post-Tuberculosis Morbidity (TB Pure)
8 week (short arm) Intervention - pulmonary rehabilitation, 24 week (long arm) Intervention - pulmonary rehabilitation - TB - Tuberculosis, TB
Not applicableRecruitingJohns Hopkins University6902026-03-182026-03-27
Leveraging mHealth to Enable and Adapt CHW Strategies to Improve TB/HIV Patient Outcomes in SA
CHW mHealth patient intervention for trigger escalation - Adherence, Patient, TB
Not applicableActive not recruitingJohns Hopkins University622022-03-102026-01-29
Impact of a Pharmacist-led Patient-centred Care Intervention Along With Text-Message Reminders, on the Management of Newly Diagnosed Tubercular Patients: a Protocol for a Randomized Controlled Trial'.
New management mode - Pulmonary TB, TB
Not applicableCompletedXi'an Jiaotong University4502020-09-012022-06-29
Comparison of the Quantiferon®-TB GOLD (in Tube) Assay With Tuberculin Skin Testing for Detecting Latent Tuberculosis Infection in Patients With Chronic Liver Disease Being Evaluated for or Awaiting Liver Transplantation
collection of blood sample - Chronic Liver Disease, TB
Not applicableWithdrawnUniversity of Pittsburgh2007-01-012020-05-07
A Study of the Immunogenicity of BCG, Delivered Intradermally in Healthy Volunteers
BCG (SSI Strain) - TB
Not applicableCompletedUniversity of Oxford102003-03-012007-05-31

Narrower conditions

Tuberculosis, Pulmonary (2)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Latent Tuberculosis (1)  ·  Patient Compliance (1)

Broader conditions

Infections (3)  ·  Actinomycetales Infections (2)  ·  Bacterial Infections (2)  ·  Bacterial Infections and Mycoses (2)  ·  Gram-Positive Bacterial Infections (2)  ·  Lung Diseases (2)  ·  Mycobacterium Infections (2)  ·  Respiratory Tract Diseases (2)  ·  Respiratory Tract Infections (2)  ·  Tuberculosis (2)  ·  Behavior (1)  ·  Blood-Borne Infections (1)  ·  Communicable Diseases (1)  ·  Genital Diseases (1)  ·  HIV Infections (1)

Interventions

Pharmaceutical Services (1)

Sponsors

Johns Hopkins University (2)  ·  University of Oxford (1)  ·  University of Pittsburgh (1)  ·  Xi'an Jiaotong University (1)

Countries

United States (2)  ·  India (1)  ·  Pakistan (1)  ·  United Kingdom (1)

Top investigators

Akshay Gupte, PhD MBBS MSPH (1)  ·  Amjad Khan, Phd (1)  ·  David L Paterson, MD (1)  ·  Fernanda Silveira, MD (1)  ·  Helen I McShane (1)  ·  Jason E Farley, PhD, MPH (1)  ·  Jonathan Golub, PhD MPH (1)  ·  Yu Fang, Phd (1)

Results publications

PMID 15502839, PMID 17957238, PMID 38356837

NIH funding

R01AI169588 (1)